Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:law
|
| gptkbp:citation |
116 Wis. 2d 166
342 N.W.2d 37 |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:date |
1984
|
| gptkbp:defendant |
gptkb:Eli_Lilly_and_Company
|
| https://www.w3.org/2000/01/rdf-schema#label |
Collins v. Eli Lilly Co.
|
| gptkbp:judge |
gptkb:Wisconsin_Supreme_Court
|
| gptkbp:jurisdiction |
gptkb:Wisconsin_Supreme_Court
|
| gptkbp:legalIssue |
DES (diethylstilbestrol) litigation
market share liability |
| gptkbp:plaintiff |
gptkb:Collins
|
| gptkbp:predecessor |
market share liability doctrine
|
| gptkbp:relatedTo |
gptkb:Sindell_v._Abbott_Laboratories
|
| gptkbp:subject |
product liability
pharmaceutical litigation |
| gptkbp:bfsParent |
gptkb:Sindell_v._Abbott_Laboratories
|
| gptkbp:bfsLayer |
7
|